Marc P Bonaca Selected Research

Stents

1/2021	Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
1/2020	The Pathobiology of Acute Limb Ischemic Events and Stent Failure in Peripheral Artery Disease: A Step in the Right Direction.
1/2020	Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.
11/2018	Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
1/2018	Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
3/2017	Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials.
3/2016	Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
1/2016	Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
12/2014	Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial.
5/2014	Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: Observations from the TIMI-38 Coronary Stent Registry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc P Bonaca Research Topics

Disease

89	Myocardial Infarction 01/2022 - 02/2007
51	Peripheral Arterial Disease 09/2022 - 09/2009
43	Hemorrhage 09/2022 - 09/2009
42	Stroke (Strokes) 09/2022 - 04/2012
28	Acute Coronary Syndrome 01/2022 - 09/2008
26	Ischemic Stroke 01/2022 - 09/2009
22	Ischemia 01/2022 - 09/2008
18	Thrombosis (Thrombus) 01/2022 - 09/2008
16	Atherosclerosis 01/2022 - 09/2009
14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
13	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 09/2008
12	Heart Failure 01/2021 - 01/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2007
9	Hypertension (High Blood Pressure) 01/2022 - 01/2011
9	Diabetes Mellitus 01/2022 - 01/2011
6	Atrial Fibrillation 09/2022 - 12/2019
6	Transient Ischemic Attack 01/2022 - 12/2014
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 04/2012
6	Vascular Diseases (Vascular Disease) 11/2018 - 04/2013
5	Inflammation (Inflammations) 01/2022 - 09/2008
5	Coronary Disease (Coronary Heart Disease) 12/2021 - 06/2016
5	Chronic Renal Insufficiency 12/2021 - 06/2014
4	Weight Loss (Weight Reduction) 01/2019 - 01/2018
4	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 02/2007
3	Venous Thromboembolism 01/2022 - 01/2018
3	Anemia 12/2021 - 01/2021
3	Overweight 01/2019 - 01/2018
3	Chest Pain (Chest Pains) 04/2014 - 09/2013
2	COVID-19 01/2022 - 01/2021
2	Intermittent Claudication 01/2022 - 10/2017
2	Infections 01/2022 - 01/2019
2	Chronic Limb-Threatening Ischemia 11/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 01/2020 - 07/2016
2	Kidney Diseases (Kidney Disease) 01/2020 - 01/2019
2	Body Weight (Weight, Body) 10/2019 - 10/2019
2	Neoplasms (Cancer) 01/2019 - 12/2018
2	Hemorrhagic Stroke 09/2016 - 12/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 12/2014
1	Embolism (Embolus) 09/2022
1	Obesity 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Unstable Angina 01/2022

Drug/Important Bio-Agent (IBA)

30	TicagrelorIBA 01/2022 - 11/2013
27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2012
26	vorapaxarIBA 01/2022 - 09/2009
18	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2016
13	RivaroxabanIBA 01/2022 - 01/2018
10	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
7	Troponin IIBA 01/2021 - 07/2012
7	dapagliflozinIBA 01/2020 - 01/2018
6	Clopidogrel (Plavix)FDA Link 12/2021 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2008
6	Neurofibromin 2 (Merlin)IBA 10/2015 - 11/2011
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 05/2014
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021 - 09/2009
5	Sodium-Glucose Transport ProteinsIBA 01/2020 - 01/2019
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
4	AnticoagulantsIBA 01/2022 - 01/2021
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 02/2007
4	LDL CholesterolIBA 01/2021 - 01/2018
4	TroponinIBA 11/2020 - 09/2008
4	Thrombin FDA Link 10/2019 - 09/2009
4	Ranolazine FDA Link 06/2014 - 01/2012
3	evolocumabIBA 12/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 01/2011
3	saxagliptin FDA Link 01/2021 - 01/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2018
3	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2009
3	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
3	lorcaserinIBA 01/2019 - 01/2018
3	Peptide Hydrolases (Proteases)FDA Link 03/2017 - 04/2013
3	thienopyridineIBA 11/2015 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2012
2	LipidsIBA 10/2021 - 01/2021
2	darapladibIBA 01/2021 - 09/2014
2	oxidized low density lipoproteinIBA 01/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2020 - 01/2011
2	SodiumIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2018
2	Growth Differentiation Factor 15IBA 01/2019 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
2	Purinergic P2Y Receptor AntagonistsIBA 05/2015 - 04/2014
1	Warfarin (Coumadin)FDA LinkGeneric 09/2022
1	edoxabanIBA 09/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Liraglutide FDA Link 01/2022
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	semaglutideIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022

Therapy/Procedure

43	Therapeutics 01/2022 - 06/2009
28	Secondary Prevention 01/2022 - 09/2009
20	Surgical Amputation (Amputations) 01/2022 - 01/2018
11	Stents 01/2021 - 01/2012
6	Percutaneous Coronary Intervention 01/2022 - 02/2007
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 03/2009
2	Exercise Therapy (Therapy, Exercise) 02/2021 - 01/2021
2	Immunotherapy 01/2019 - 12/2018
1	Vascular Surgical Procedures 01/2022